查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
迷幻藥市場，按藥物類型、按應用、分銷管道、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1351417

迷幻藥市場，按藥物類型、按應用、分銷管道、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Psychedelic Drugs Market, by Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年迷幻藥市場規模為48.7012億美元，2023年至2030年年複合成長率為13.46%。

雖然這些化學製劑因其潛在的治療和精神應用而引起了科學界的關注，但它們的使用存在固有的風險。這些危害包括個人在接觸這些物質時可能遇到的不良副作用和心理挑戰。

迷幻藥市場 - 市場動態：

  • 提高人們對解決心理健康問題重要性的認知
  • 市場的成長很大程度上取決於對解決城市擁擠和交通效率低下挑戰的解決方案的需求。新興技術和創新的出行解決方案在重新定義城市交通景觀方面發揮關鍵作用，為緩解交通堵塞和減少環境影響提供了新穎的方法。在整個預測期內，預計促進永續城市交通的政府措施、公私合作和宣傳活動將推動市場擴張。
  • 例如，近幾十年來，城市交通基金會等組織率先發起了旨在改變城市交通模式的措施。他們的努力促成了永續交通實踐的開發和採用，為更有效率、更環保的城市通勤選擇做出了貢獻。

迷幻藥市場 - 主要見解：

  • 根據我們的研究分析師提供的見解，全球迷幻藥物市場將經歷強勁的年成長率，預計 2023 年至 2030 年的預測期內年複合成長率 (CAGR) 約為 14.2%。
  • 該行業的成長軌跡受到重要因素的支撐，主要是人們越來越認知到在全球範圍內解決心理健康挑戰的迫切需求。
  • 在藥物分類領域，裸蓋菇素細分市場在 2022 年的市場佔有率方面佔據主導地位。
  • 此外，在考慮應用細分時，與難治性憂鬱症治療相關的類別在 2022 年脫穎而出，成為領跑者。
  • 從分銷管道來看，2022年醫院在市場佔有率方面處於領先地位。
  • 從地域角度來看，北美地區將成為 2022 年的主要收入來源。

迷幻藥市場-細分分析：

  • 全球迷幻藥市場呈現全面的細分結構，以藥物類型、應用、技術和地理區域作為主要分類。
  • 在藥物類型分類範圍內，市場呈現多種類別，包括氯胺酮、γ-羥基丁酸(GHB)、麥角酸二乙醯胺(LSD)、賽洛西賓、3,4-甲基烯二氧基甲基安非他命和各種其他藥物類型。值得注意的是，目前市場格局由裸蓋菇素主導。這種特殊的化合物一直處於臨床研究的前沿，研究重點是其治療成癮、焦慮、憂鬱和臨終痛苦等一系列疾病的潛在功效。初步研究結果揭示了有希望的結果，激發了人們對基於裸蓋菇素的治療方式的開發的極大興趣和財政支持。

迷幻藥市場-競爭格局：

企業採用多種策略將產品推向市場，利用一系列分銷管道，如企業網站、線上零售平台、實體零售商、分銷​​合作夥伴和直接面對消費者的模式。產品製造商在定價策略、產品性能、製造技術、技術創新、品牌聲譽和產品可用性等多個方面競爭。

為了鞏固市場地位並擴大市場佔有率，公司採用了一系列策略。其中包括透過新產品發布增強產品組合、擴大分銷網路、增加研發投資以及參與併購。

例如，2022 年 10 月，Numinus Wellness Inc.（一家致力於推進實證安全迷幻輔助治療的精神保健組織）推出了氯胺酮治療嚴重和慢性疾病計劃。這項創新措施預計將首先在位於不列顛哥倫比亞省、猶他州和魁北克省的 Numinus 診所推出，這標誌著透過新穎的治療途徑解決醫療問題的漸進方法。

目錄

第一章：迷幻藥市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按藥物類型分類的迷幻藥物市場片段
    • 迷幻藥市場片段（按應用）
    • 迷幻藥市場片段（依分佈）
    • 按國家/地區分類的迷幻藥物市場片段
    • 按地區分類的迷幻藥市場片段
  • 競爭洞察

第 3 章：迷幻藥主要市場趨勢

  • 迷幻藥市場促進因素
    • 市場促進因素的影響分析
  • 迷幻藥市場限制
    • 市場限制影響分析
  • 迷幻藥市場機會
  • 迷幻藥市場未來趨勢

第 4 章：迷幻藥物產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：迷幻藥市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：迷幻藥市場格局

  • 2022 年迷幻藥市佔率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：迷幻藥市場 - 依藥物類型

  • 概述
    • 按藥物類型分類的細分市場佔有率分析
    • 氯胺酮
    • γ-羥基丁酸 (GHB)
    • 麥角酸二乙醯胺 (LSD)
    • 裸蓋菇素
    • 3,4-甲基烯二氧基甲基苯丙胺
    • 其他藥物類型

第 8 章：迷幻藥市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 鴉片成癮
    • 難治性憂鬱症
    • 發作性睡病
    • 創傷後壓力症候群
    • 恐慌症
    • 其他應用

第 9 章：迷幻藥市場 - 按分佈

  • 概述
    • 按分佈分類的細分市場佔有率分析
    • 零售藥房
    • 醫院藥房
    • 線上分銷通路

第 10 章：迷幻藥市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美迷幻藥主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按藥物類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按分佈）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲迷幻藥主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按藥物類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模與預測（按分佈）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區迷幻藥主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按藥物類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模與預測（按分佈）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲迷幻藥主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按藥物類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模與預測（按分佈）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲迷幻藥主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按藥物類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按分佈）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 迷幻藥物產業

  • 競爭儀表板
  • 公司簡介
    • Silo Wellness
    • Revive Therapeutics
    • PsyBio Therapeutics
    • Numinus Wellness
    • Mydecine Innovations Group
    • MindMed
    • MagicMed Industries
    • Field Trip Health
    • Entheon Biomedical
    • Eleusis Ltd.
    • Cybin Inc.
    • Compass Pathways
    • Bright Minds Biosciences
    • Beckley Psytech
    • Atai Life Sciences

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1666

REPORT HIGHLIGHT

Psychedelic Drugs Market size was valued at USD 4,870.12 Million in 2022, expanding at a CAGR of 13.46% from 2023 to 2030.

Substances categorized as "psychedelics" possess the capacity to induce profound alterations in perception, cognitive processes, and emotional states, often leading to intense sensory encounters and potentially life-altering insights. This category includes substances like psilocybin mushrooms, DMT (dimethyltryptamine), and LSD (lysergic acid diethylamide). These compounds exert their effects by targeting specific receptors in the brain, resulting in hallucinogenic phenomena, heightened emotional responses, and shifts in consciousness.

While these chemical agents have garnered scientific attention for their potential therapeutic and spiritual applications, their usage carries inherent risks. These hazards encompass adverse side effects and psychological challenges that individuals may encounter when engaging with these substances.

Psychedelic Drugs Market - Market Dynamics:

  • Increasing awareness about the importance of addressing mental health concerns
  • The growth of the market is significantly shaped by the demand for solutions addressing the challenges of urban congestion and transportation inefficiencies. Emerging technologies and innovative mobility solutions are playing a pivotal role in redefining urban transportation landscapes, offering novel approaches to alleviate traffic congestion and reduce environmental impact. Throughout the forecasted period, it is anticipated that government initiatives, public-private collaborations, and advocacy campaigns promoting sustainable urban mobility will drive market expansion.
  • For example, in recent decades, organizations like the Urban Mobility Foundation have spearheaded initiatives aimed at transforming urban transportation paradigms. Their efforts have resulted in the development and adoption of sustainable mobility practices, contributing to more efficient and eco-friendly urban commuting options.

Psychedelic Drugs Market - Key Insights:

  • As per the insights provided by our research analysts, the global Market for Psychedelic Drugs is poised to experience a robust annual growth rate, with a projected Compound Annual Growth Rate (CAGR) of approximately 14.2% throughout the forecast period spanning from 2023 to 2030.
  • This industry's growth trajectory is underpinned by significant factors, primarily the increasing recognition of the critical need to address mental health challenges on a global scale.
  • Within the realm of drug categorization, the segment dedicated to psilocybin emerged as the dominant player in terms of market share for the year 2022.
  • Furthermore, when considering application segmentation, the category related to the treatment of resistant depression stood out as the frontrunner in 2022.
  • Examining distribution channels, hospitals took the lead in 2022 in terms of market presence.
  • In geographical terms, North America emerged as the primary revenue contributor in the year 2022.

Psychedelic Drugs Market- Segmentation Analysis:

  • The Global Market for Psychedelic Drugs exhibits a comprehensive segmentation structure, incorporating Drug Type, Application, Technology, and Geographical Region as its key categorizations.
  • Within the spectrum of Drug Type classification, the market presents a diverse array of categories, including Ketamine, Gamma Hydroxybutyric Acid (GHB), Lysergic Acid Diethylamide (LSD), Psilocybin, 3,4-MethylEnedioxyMethamphetamine, and various other drug types. Notably, the market's landscape is currently dominated by Psilocybin. This particular compound has been at the forefront of clinical investigations, with studies focusing on its potential efficacy in treating a spectrum of conditions such as addiction, anxiety, depression, and end-of-life distress. The preliminary research findings have unveiled promising outcomes, prompting considerable interest and financial support for the development of treatment modalities based on Psilocybin.

Psychedelic Drugs Market- Competitive Landscape:

Enterprises employ diverse strategies to bring their products to market, utilizing an array of distribution channels such as corporate websites, online retail platforms, brick-and-mortar retailers, distribution partners, and direct-to-consumer models. Product manufacturers engage in competition across multiple fronts, including pricing strategies, product performance, manufacturing techniques, technological innovation, brand reputation, and product availability.

To fortify their market presence and expand their market share, companies employ a range of tactics. These include product portfolio enhancements through new product launches, the expansion of distribution networks, increased investments in research and development, and participation in mergers and acquisitions.

For instance, in October 2022, Numinus Wellness Inc., a mental health care organization dedicated to advancing evidence-based, safe psychedelic-assisted treatments, introduced its Ketamine for Serious and Chronic Medical Illness Program. This innovative initiative is expected to roll out initially in Numinus clinics located in British Columbia, Utah, and Quebec, signifying a progressive approach to addressing medical conditions through novel therapeutic avenues.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PSYCHEDELIC DRUGS MARKET KEY PLAYERS

  • Silo Wellness
  • Revive Therapeutics
  • PsyBio Therapeutics
  • Numinus Wellness
  • Mydecine Innovations Group
  • MindMed
  • MagicMed Industries
  • Field Trip Health
  • Entheon Biomedical
  • Eleusis Ltd.
  • Cybin Inc.
  • Compass Pathways
  • Bright Minds Biosciences
  • Beckley Psytech
  • Atai Life Sciences

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DRUG TYPE

  • Ketamine
  • Gamma Hydroxybutyric Acid (GHB)
  • Lysergic Acid Diethylamide (LSD)
  • Psilocybin
  • 3,4-MethylEnedioxyMethamphetamine
  • Other Drug Types

GLOBAL PSYCHEDELIC DRUGS MARKET, BY APPLICATION

  • Opiate Addiction
  • Treatment-Resistant Depression
  • Narcolepsy
  • Post-traumatic Stress Disorder
  • Panic Disorder
  • Others Applications

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Distribution Channel

GLOBAL PSYCHEDELIC DRUGS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Psychedelic Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Psychedelic Drugs Market Snippet by Drug Type
    • 2.1.2. Psychedelic Drugs Market Snippet by Application
    • 2.1.3. Psychedelic Drugs Market Snippet by Distribution
    • 2.1.4. Psychedelic Drugs Market Snippet by Country
    • 2.1.5. Psychedelic Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Psychedelic Drugs Key Market Trends

  • 3.1. Psychedelic Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Psychedelic Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Psychedelic Drugs Market Opportunities
  • 3.4. Psychedelic Drugs Market Future Trends

4. Psychedelic Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Psychedelic Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Psychedelic Drugs Market Landscape

  • 6.1. Psychedelic Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Psychedelic Drugs Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
    • 7.1.2. Ketamine
    • 7.1.3. Gamma Hydroxybutyric Acid (GHB)
    • 7.1.4. Lysergic Acid Diethylamide (LSD)
    • 7.1.5. Psilocybin
    • 7.1.6. 3,4-MethylEnedioxyMethamphetamine
    • 7.1.7. Other Drug Types

8. Psychedelic Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Opiate Addiction
    • 8.1.3. Treatment-Resistant Depression
    • 8.1.4. Narcolepsy
    • 8.1.5. Post-traumatic Stress Disorder
    • 8.1.6. Panic Disorder
    • 8.1.7. Others Applications

9. Psychedelic Drugs Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2022 & 2030 (%)
    • 9.1.2. Retail Pharmacy
    • 9.1.3. Hospital Pharmacy
    • 9.1.4. Online Distribution Channel

10. Psychedelic Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Psychedelic Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Psychedelic Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Psychedelic Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Psychedelic Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Psychedelic Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Psychedelic Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Silo Wellness
    • 11.2.2. Revive Therapeutics
    • 11.2.3. PsyBio Therapeutics
    • 11.2.4. Numinus Wellness
    • 11.2.5. Mydecine Innovations Group
    • 11.2.6. MindMed
    • 11.2.7. MagicMed Industries
    • 11.2.8. Field Trip Health
    • 11.2.9. Entheon Biomedical
    • 11.2.10. Eleusis Ltd.
    • 11.2.11. Cybin Inc.
    • 11.2.12. Compass Pathways
    • 11.2.13. Bright Minds Biosciences
    • 11.2.14. Beckley Psytech
    • 11.2.15. Atai Life Sciences

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Psychedelic Drugs Market: Drug Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global Psychedelic Drugs Market, by Drug Type 2018-2030 (USD Million)
  • TABLE Psychedelic Drugs Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Psychedelic Drugs Market, by Application 2018-2030 (USD Million)
  • TABLE Psychedelic Drugs Market: Distribution Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Psychedelic Drugs Market, by Distribution 2018-2030 (USD Million)
  • TABLE Psychedelic Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Psychedelic Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)

List of Figures

  • FIGURE Psychedelic Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Type segment market share analysis, 2022 & 2030
  • FIGURE Drug Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution segment market share analysis, 2022 & 2030
  • FIGURE Distribution segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Europe Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Latin America Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Psychedelic Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE Germany Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE India Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE Brazil Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)